Abstract
The splenomegaly associated with myelofibrosis and agnogenic myeloid metaplasia should not be considered a manifestation of the fundamental proliferative process, nor should it be considered as necessarily compensatory for reduced marrow haematopoiesis.
In deserving cases splenectomy may cause an improvement in the patient's general and haematopoietic status. Removal of the source of functional hypersplenism, causing haemolytic episodes and thrombocytopenia, results in marked amelioration in the clinical condition with reduction in the magnitude and frequency of replacement blood transfusion.
The massive size of the spleen associated with this condition may not only cause local pain and discomfort but may lead to traumatic or spontaneous rupture.
Consideration of two cases studied by the authors indicates that marked clinical improvement may be associated with splenectomy in selected cases of agnogenic myeloid metaplasia.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BETHELL F. H., LINMAN J. W. Agnogenic myeloid metaplasia: its natural history and present day management. Am J Med. 1957 Jan;22(1):107–122. doi: 10.1016/0002-9343(57)90342-x. [DOI] [PubMed] [Google Scholar]
- DAMESHEK W. Some speculations on the myeloproliferative syndromes. Blood. 1951 Apr;6(4):372–375. [PubMed] [Google Scholar]
- FISHMAN N., BALLINGER W. F., 2nd SPLENECTOMY FOR AGNOGENIC MYELOID METAPLASIA AND MYELOFIBROSIS. Arch Surg. 1965 Feb;90:240–246. doi: 10.1001/archsurg.1965.01320080064015. [DOI] [PubMed] [Google Scholar]
- GREEN T. W., CONLEY C. L., ASHBURN L. L., PETERS H. R. Splenectomy for myeloid metaplasia of the spleen. N Engl J Med. 1953 Feb 5;248(6):211–219. doi: 10.1056/NEJM195302052480601. [DOI] [PubMed] [Google Scholar]
- HUTT M. S. R., PINNIGER J. L., WETHERLEY-MEIN G. The myeloproliferative disorders with special reference to myelofibrosis. Blood. 1953 Apr;8(4):295–314. [PubMed] [Google Scholar]
- SZUR L., SMITH M. D. Red-cell production and destruction in myelosclerosis. Br J Haematol. 1961 Apr;7:147–168. doi: 10.1111/j.1365-2141.1961.tb00326.x. [DOI] [PubMed] [Google Scholar]
- WASSERMAN L. R. Polycythemia vera: its course and treatment; relation to myeloid metaplasia and leukemia. Bull N Y Acad Med. 1954 May;30(5):343–375. [PMC free article] [PubMed] [Google Scholar]
- WYATT J. P., SOMMERS S. C. Chronic marrow failure, myelosclerosis and extramedullary hematopoiesis. Blood. 1950 Apr;5(4):329–347. [PubMed] [Google Scholar]